Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients.

MLA

Schmidt, K. L.Juliëtte, et al. “Immune Response Following BNT162b2 MRNA COVID-19 Vaccination in Pediatric Cancer Patients.” Cancers, vol. 15, no. 9, Apr. 2023. EBSCOhost, https://doi.org/10.3390/cancers15092562.

APA

Schmidt, K. L. J., Dautzenberg, N. M. M., Hoogerbrugge, P. M., Lindemans, C. A., Nierkens, S., Smits, G., Van Binnendijk, R. S., Bont, L. J., & Tissing, W. J. E. (2023). Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients. Cancers, 15(9). https://doi.org/10.3390/cancers15092562

Chicago

Schmidt, K L Juliëtte, Noël M M Dautzenberg, Peter M Hoogerbrugge, Caroline A Lindemans, Stefan Nierkens, Gaby Smits, Rob S Van Binnendijk, Louis J Bont, and Wim J E Tissing. 2023. “Immune Response Following BNT162b2 MRNA COVID-19 Vaccination in Pediatric Cancer Patients.” Cancers 15 (9). doi:10.3390/cancers15092562.